Skip to Main Content

2,983

Views

15

CrossRef citations to date

0

Altmetric

Original Article: Clinical

Real-world effectiveness of brentuximab vedotin versus physicians’ choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany

Erin A. ZagadailovMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information

,

Shelby CormanPharmerit International, Bethesda, MD, USA; View further author information

,

Viktor ChirikovPharmerit International, Bethesda, MD, USA; View further author information

,

Courtney JohnsonPharmerit International, Bethesda, MD, USA; View further author information

,

Cynthia MacahiligMedical Data Analytics, Parsippany, NJ, USA; View further author information

,

Brian SealAstraZeneca, Gaithersburg, MD, USA; View further author information

,

Mehul R. DalalMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information

,

Paul J. BröckelmannDepartment I of Internal Medicine and German Hodgkin Study Group, University Hospital of Cologne, Cologne, Germany; View further author information

&

Tim IllidgeInstitute of Cancer Sciences, University of Manchester, Christie Hospital, Manchester, UKCorrespondence[email protected]
View further author information